Research ExplorerPublicationsApplication of the SCAI classification in a cohort of patien...

Application of the SCAI classification in a cohort of patients with cardiogenic shock

Standard

Application of the SCAI classification in a cohort of patients with cardiogenic shock. / Schrage, Benedikt; Dabboura, Salim; Yan, Isabell; Hilal, Rafel; Neumann, Johannes T; Sörensen, Nils A; Goßling, Alina; Becher, Peter Moritz; Grahn, Hanno; Wagner, Tobias; Seiffert, Moritz; Kluge, Stefan; Reichenspurner, Hermann; Blankenberg, Stefan; Westermann, Dirk.

In: CATHETER CARDIO INTE, Vol. 96, No. 3, 01.09.2020, p. E213-E219.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Schrage, B, Dabboura, S, Yan, I, Hilal, R, Neumann, JT, Sörensen, NA, Goßling, A, Becher, PM, Grahn, H, Wagner, T, Seiffert, M, Kluge, S, Reichenspurner, H, Blankenberg, S & Westermann, D 2020, 'Application of the SCAI classification in a cohort of patients with cardiogenic shock', CATHETER CARDIO INTE, vol. 96, no. 3, pp. E213-E219. https://doi.org/10.1002/ccd.28707

APA

Schrage, B., Dabboura, S., Yan, I., Hilal, R., Neumann, J. T., Sörensen, N. A., Goßling, A., Becher, P. M., Grahn, H., Wagner, T., Seiffert, M., Kluge, S., Reichenspurner, H., Blankenberg, S., & Westermann, D. (2020). Application of the SCAI classification in a cohort of patients with cardiogenic shock. CATHETER CARDIO INTE, 96(3), E213-E219. https://doi.org/10.1002/ccd.28707

Vancouver

Schrage B, Dabboura S, Yan I, Hilal R, Neumann JT, Sörensen NA et al. Application of the SCAI classification in a cohort of patients with cardiogenic shock. CATHETER CARDIO INTE. 2020 Sep 1;96(3):E213-E219. https://doi.org/10.1002/ccd.28707

Bibtex

@article{0964f68b1d0e45bd8b1eb55d3a4ad28a,
title = "Application of the SCAI classification in a cohort of patients with cardiogenic shock",
abstract = "BACKGROUND: The Society of Cardiovascular Angiography and Interventions (SCAI) have recently proposed a new classification of cardiogenic shock (CS) dividing patients into five subgroups.OBJECTIVE: Aim of this study was to apply the SCAI classification to a cohort of patients presenting with CS and to evaluate its ability to predict 30-day survival.METHODS: SCAI CS subgroups were interpreted based on the recent consensus statement and then applied to N = 1,007 consecutive patients presenting with CS or large myocardial infarction (MI) between October 2009 and October 2017. The association between SCAI classification and 30-day all-cause mortality was assessed by logistic regression analysis.RESULTS: Mean age in the study cohort was 67 (±15) years, 72% were male. Mean lactate at baseline was 6.05 (±5.13) mmol/l and 51% of the patients had prior cardiac arrest. Overall survival probability was 50.6% (95% confidence interval [CI] 47.5-54.0%). In view of the SCAI classification, the survival probability was 96.4% (95% CI 93.7-99.0%) in class A, 66.1% (95% CI 50.2-87.1%) in class B, 46.1% (95% CI 40.6-52.4%) in class C, 33.1% (95% CI 26.6-41.1%) in class D, and 22.6% (95% CI 17.1-30.0%) in class E. Higher SCAI classification was significantly associated with lower 30-day survival (p < .01).CONCLUSION: In this large clinical cohort, the SCAI classification was significantly associated with 30-day survival. This finding supports the rationale of the SCAI CS classification and calls for a validation in a prospective trial.",
author = "Benedikt Schrage and Salim Dabboura and Isabell Yan and Rafel Hilal and Neumann, {Johannes T} and S{\"o}rensen, {Nils A} and Alina Go{\ss}ling and Becher, {Peter Moritz} and Hanno Grahn and Tobias Wagner and Moritz Seiffert and Stefan Kluge and Hermann Reichenspurner and Stefan Blankenberg and Dirk Westermann",
note = "{\textcopyright} 2020 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals, Inc.",
year = "2020",
month = sep,
day = "1",
doi = "10.1002/ccd.28707",
language = "English",
volume = "96",
pages = "E213--E219",
journal = "CATHETER CARDIO INTE",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "3",

}

RIS

TY - JOUR

T1 - Application of the SCAI classification in a cohort of patients with cardiogenic shock

AU - Schrage, Benedikt

AU - Dabboura, Salim

AU - Yan, Isabell

AU - Hilal, Rafel

AU - Neumann, Johannes T

AU - Sörensen, Nils A

AU - Goßling, Alina

AU - Becher, Peter Moritz

AU - Grahn, Hanno

AU - Wagner, Tobias

AU - Seiffert, Moritz

AU - Kluge, Stefan

AU - Reichenspurner, Hermann

AU - Blankenberg, Stefan

AU - Westermann, Dirk

N1 - © 2020 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals, Inc.

PY - 2020/9/1

Y1 - 2020/9/1

N2 - BACKGROUND: The Society of Cardiovascular Angiography and Interventions (SCAI) have recently proposed a new classification of cardiogenic shock (CS) dividing patients into five subgroups.OBJECTIVE: Aim of this study was to apply the SCAI classification to a cohort of patients presenting with CS and to evaluate its ability to predict 30-day survival.METHODS: SCAI CS subgroups were interpreted based on the recent consensus statement and then applied to N = 1,007 consecutive patients presenting with CS or large myocardial infarction (MI) between October 2009 and October 2017. The association between SCAI classification and 30-day all-cause mortality was assessed by logistic regression analysis.RESULTS: Mean age in the study cohort was 67 (±15) years, 72% were male. Mean lactate at baseline was 6.05 (±5.13) mmol/l and 51% of the patients had prior cardiac arrest. Overall survival probability was 50.6% (95% confidence interval [CI] 47.5-54.0%). In view of the SCAI classification, the survival probability was 96.4% (95% CI 93.7-99.0%) in class A, 66.1% (95% CI 50.2-87.1%) in class B, 46.1% (95% CI 40.6-52.4%) in class C, 33.1% (95% CI 26.6-41.1%) in class D, and 22.6% (95% CI 17.1-30.0%) in class E. Higher SCAI classification was significantly associated with lower 30-day survival (p < .01).CONCLUSION: In this large clinical cohort, the SCAI classification was significantly associated with 30-day survival. This finding supports the rationale of the SCAI CS classification and calls for a validation in a prospective trial.

AB - BACKGROUND: The Society of Cardiovascular Angiography and Interventions (SCAI) have recently proposed a new classification of cardiogenic shock (CS) dividing patients into five subgroups.OBJECTIVE: Aim of this study was to apply the SCAI classification to a cohort of patients presenting with CS and to evaluate its ability to predict 30-day survival.METHODS: SCAI CS subgroups were interpreted based on the recent consensus statement and then applied to N = 1,007 consecutive patients presenting with CS or large myocardial infarction (MI) between October 2009 and October 2017. The association between SCAI classification and 30-day all-cause mortality was assessed by logistic regression analysis.RESULTS: Mean age in the study cohort was 67 (±15) years, 72% were male. Mean lactate at baseline was 6.05 (±5.13) mmol/l and 51% of the patients had prior cardiac arrest. Overall survival probability was 50.6% (95% confidence interval [CI] 47.5-54.0%). In view of the SCAI classification, the survival probability was 96.4% (95% CI 93.7-99.0%) in class A, 66.1% (95% CI 50.2-87.1%) in class B, 46.1% (95% CI 40.6-52.4%) in class C, 33.1% (95% CI 26.6-41.1%) in class D, and 22.6% (95% CI 17.1-30.0%) in class E. Higher SCAI classification was significantly associated with lower 30-day survival (p < .01).CONCLUSION: In this large clinical cohort, the SCAI classification was significantly associated with 30-day survival. This finding supports the rationale of the SCAI CS classification and calls for a validation in a prospective trial.

U2 - 10.1002/ccd.28707

DO - 10.1002/ccd.28707

M3 - SCORING: Journal article

C2 - 31925996

VL - 96

SP - E213-E219

JO - CATHETER CARDIO INTE

JF - CATHETER CARDIO INTE

SN - 1522-1946

IS - 3

ER -